Pharmacological postconditioning with the phytoestrogen genistein

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 1, 2007, Pages 79-87

  Tissier, R ^a,b,c   Waintraub, X ^a,b,c   Couvreur, N ^a,b,c   Gervais, M ^f   Bruneval, P ^e   Mandet, C ^e   Zini, R ^a,b,c   Enriquez, B ^a,b,c   Berdeaux, A ^a,b,c,d   Ghaleh, B ^a,b,c,d  

^a INSERM   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

^f CNRS   (France)

Author keywords

Cardioprotection; Estradiol; Estrogens; Genistein; Infarction; Ischemia; Mitochondria; Phytoestrogens; Postconditioning; Rabbit; Reperfusion

Indexed keywords

ESTRADIOL; FULVESTRANT; GENISTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHYTOESTROGEN; PROTEIN KINASE B INHIBITOR; PROTEIN TYROSINE KINASE; SODIUM CHLORIDE; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ESTROGEN ACTIVITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HORMONE RECEPTOR INTERACTION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MALE; MITOCHONDRION SWELLING; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CALCIUM; CARDIOTONIC AGENTS; ESTRADIOL; GENISTEIN; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MITOCHONDRIA, HEART; MITOCHONDRIAL SWELLING; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PHYTOESTROGENS; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; RECEPTORS, ESTROGEN;

ORYCTOLAGUS CUNICULUS;

EID: 33845636194     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.10.007     Document Type: Article

References (47)

1. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial. JAMA 291 (2004) 1701-1712
2. Manson J.E., Hsia J., Johnson K.C., Rossouw J.E., Assaf A.R., Lasser N.L., et al. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349 (2003) 523-534
3. Ouyang P., Michos E.D., and Karas R.H. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J. Am. Coll. Cardiol. 47 (2006) 1741-1753
4. McNulty P.H., Jagasia D., Whiting J.M., and Caulin Glaser T. Effect of 6 wk estrogen withdrawal or replacement on myocardial ischemic tolerance in rats. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1030-H1034
5. van Eickels M., Patten R.D., Aronovitz M.J., Alsheikh Ali A., Gostyla K., Celestin F., et al. 17 beta estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J. Am. Coll. Cardiol. 41 (2003) 2084-2092
6. Zhai P., Eurell T.E., Cotthaus R.P., Jeffery E.H., Bahr J.M., and Gross D.R. Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H1223-H1232
7. Lee T.M., Lin M.S., Chou T.F., Tsai C.H., and Chang N.C. Adjunctive 17beta-estradiol administration reduces infarct size by altered expression of canine myocardial connexin43 protein. Cardiovasc. Res. 63 (2004) 109-117
8. Lee T.M., Su S.F., Tsai C.C., Lee Y.T., and Tsai C.H. Cardioprotective effects of 17 beta-estradiol produced by activation of mitochondrial ATP-sensitive K(+)Channels in canine hearts. J. Mol. Cell Cardiol. 32 (2000) 1147-1158
9. Tsai C.H., Su S.F., Chou T.F., and Lee T.M. Differential effects of sarcolemmal and mitochondrial K(ATP) channels activated by 17 beta-estradiol on reperfusion arrhythmias and infarct sizes in canine hearts. J. Pharmacol. Exp. Ther. 301 (2002) 234-240
10. Booth E.A., Marchesi M., Kilbourne E.J., and Lucchesi B.R. 17Beta-estradiol as a receptor-mediated cardioprotective agent. J. Pharmacol. Exp. Ther. 307 (2003) 395-401
11. Booth E.A., Obeid N.R., and Lucchesi B.R. Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H2039-H2047
12. Hale S.L., Birnbaum Y., and Kloner R.A. beta-Estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am. Heart J. 132 (1996) 258-262
13. Hale S.L., Birnbaum Y., and Kloner R.A. Estradiol, administered acutely, protects ischemic myocardium in both female and male rabbits. J. Cardiovasc. Pharmacol. Ther. 2 (1997) 47-52
14. Lee T.M., Su S.F., Chou T.F., and Tsai C.H. Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty. J. Am. Coll. Cardiol. 39 (2002) 871-877
15. Lee T.M., Chou T.F., and Tsai C.H. Differential role of K(ATP) channels activated by conjugated estrogens in the regulation of myocardial and coronary protective effects. Circulation 107 (2003) 49-54
16. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J. Am. Coll. Cardiol. 44 (2004) 1103-1110
17. Patten R.D., and Karas R.H. Estrogen replacement and cardiomyocyte protection. Trends Cardiovasc. Med. 16 (2006) 69-75
18. Patten R.D., Pourati I., Aronovitz M.J., Baur J., Celestin F., Chen X., et al. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ. Res. 95 (2004) 692-699
19. Hausenloy D.J., Tsang A., and Yellon D.M. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc. Med. 15 (2005) 69-75
20. Tsang A., Hausenloy D.J., Mocanu M.M., and Yellon D.M. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ. Res. 95 (2004) 230-232
21. Delyani J.A., Murohara T., Nossuli T.O., and Lefer A.M. Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol. J. Mol. Cell Cardiol. 28 (1996) 1001-1008
22. Lissin L.W., and Cooke J.P. Phytoestrogens and cardiovascular health. J. Am. Coll. Cardiol. 35 (2000) 1403-1410
23. Dubey R.K., Gillespie D.G., Imthurn B., Rosselli M., Jackson E.K., and Keller P.J. Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension 33 (1999) 177-182
24. Figtree G.A., Griffiths H., Lu Y.Q., Webb C.M., MacLeod K., and Collins P. Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J. Am. Coll. Cardiol. 35 (2000) 1977-1985
25. Souzeau E., Belanger S., Picard S., and Deschepper C.F. Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H715-H721
26. Walker H.A., Dean T.S., Sanders T.A., Jackson G., Ritter J.M., and Chowienczyk P.J. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol. Circulation 103 (2001) 258-262
27. Deodato B., Altavilla D., Squadrito G., Campo G.M., Arlotta M., Minutoli L., et al. Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury. Br. J. Pharmacol. 128 (1999) 1683-1690
28. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262 (1987) 5592-5595
29. Fryer R.M., Schultz J.E., Hsu A.K., and Gross G.J. Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in rat hearts. Am. J. Physiol. 275 (1998) H2009-H2015
30. Argaud L., Gateau-Roesch O., Raisky O., Loufouat J., Robert D., and Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 111 (2005) 194-197
31. Tessier-Vetzel D., Tissier R., Waintraub X., Ghaleh B., and Berdeaux A. Isoflurane inhaled at the onset of reperfusion potentiates the cardioprotective effect of ischemic postconditioning through a NO-dependent mechanism. J. Cardiovasc. Pharmacol. 47 (2006) 487-492
32. Tissier R., Aouam K., Berdeaux A., and Ghaleh B. Evidence for a ceiling of cardioprotection with a nitric oxide donor-induced delayed preconditioning in rabbits. J. Pharmacol. Exp. Ther. 306 (2003) 528-531
33. Tissier R., Souktani R., Bruneval P., Giudicelli J.F., Berdeaux A., and Ghaleh B. Adenosine A(1)-receptor induced late preconditioning and myocardial infarction: reperfusion duration is critical. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H38-H43
34. Morin C., Zini R., and Tillement J.P. Anoxia-reoxygenation-induced cytochrome c and cardiolipin release from rat brain mitochondria. Biochem. Biophys. Res. Commun. 307 (2003) 477-482
35. Hattori R., Otani H., Uchiyama T., Imamura H., Cui J., Maulik N., et al. Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H1066-H1074
36. Weis S., Shintani S., Weber A., Kirchmair R., Wood M., Cravens A., et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J. Clin. Invest. 113 (2004) 885-894
37. Howell A. Faslodex (ICI 182780). An oestrogen receptor downregulator. Eur. J. Cancer 36 Suppl. 4 (2000) S87-S88
38. Nuttall M.E., Pendrak I., Emery J.G., Nadeau D.P., Fisher P.W., Nicholson T.A., et al. Antagonism of oestrogen action in human breast and endometrial cells in vitro: potential novel antitumour agents. Cancer Chemother. Pharmacol. 47 (2001) 437-443
39. Lee G.S., Choi K.C., Kim H.J., and Jeung E.B. Effect of genistein as a selective estrogen receptor beta agonist on the expression of Calbindin-D9k in the uterus of immature rats. Toxicol. Sci. 82 (2004) 451-457
40. Yang X.M., Philipp S., Downey J.M., and Cohen M.V. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res. Cardiol. 100 (2005) 57-63
41. Chiari P.C., Bienengraeber M.W., Pagel P.S., Krolikowski J.G., Kersten J.R., and Warltier D.C. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 102 (2005) 102-109
42. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., and Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 (2000) 538-541
43. Nuedling S., Kahlert S., Loebbert K., Meyer R., Vetter H., and Grohe C. Differential effects of 17beta-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes. FEBS Lett. 454 (1999) 271-276
44. Franke T.F., Hornik C.P., Segev L., Shostak G.A., and Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 22 (2003) 8983-8998
45. Davidson S.M., Hausenloy D., Duchen M.R., and Yellon D.M. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int. J. Biochem. Cell Biol. 38 (2006) 414-419
46. Nascimento C.A., Kauser K., and Rubanyi G.M. Effect of 17beta-estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction. Am. J. Physiol. 276 (1999) H1788-H1794
47. Watanabe Y., Littleton-Kearney M.T., Traystman R.J., and Hurn P.D. Estrogen restores postischemic pial microvascular dilation. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H155-H160